Richard Geary
Fortuna: 5 M $ al 31/05/2026
Fortuna: 5 M $ al 31/05/2026
Richard S.
Geary is currently Director at Oligonucleotide Therapeutics Society, Inc. Formerly, Dr. Geary was Vice President-Preclinical Development at Ionis Pharmaceuticals, Inc. from 2003 to 2008 and worked at Southwest Research Institute as Senior Research Scientist.
Education includes undergraduate studies at Texas A&M University and a doctorate from The University of Texas at Austin conferred in 1987.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 59.657 ( 0,04 % ) | 5 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2026 |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.